TriNet Group, Inc.
TriNet Group, Inc. Q4 FY2025 earnings call
February 12, 2026 · fiscal period ended 2025-12
EPS · actual vs est
Revenue · actual vs est
Summary
Generated 2026-02-12
Management highlights
• 2025 was challenging with SMB landscape issues, but TriNet executed well, delivered solid financials, improved pricing processes, and made progress on initiatives. • Growth-focused investments in 2025 starting to take hold: sales up in Jan, broker channel strong, improved sales organization, simplified PEO health plan offering, ASO as core growth driver. • Achieved all-time high net promoter score in 2025, launching TriNet Assistant AI-powered HR tool and enhancing client experience through integrations. • Exiting 2025 with expenses down 7% year over year and expecting further improvement in 2026.
Segment performance
Total revenues declined 2% year over year in Q4 and 1% for full year 2025. Professional services revenue declined 7% in Q4 and 6% for full year. Insurance services revenues declined 1% in Q4 and were flat for full year. ASO business had strong growth. Free cash flow grew 16% in 2025. Retention dropped to ~80% in 2025. WSEs ended 2025 at ~320,000, down 10% year over year with co-employed WSEs at 294,000, down 11%.
Guidance
• 2026 total revenues expected $4.75B - $4.90B. • CIE midpoint growth low single digits. • Interest income expected $25M - $30M headwind vs 2025. • Professional services revenue $625M - $645M with drivers like WSE forecast, ASO growth, legacy SaaS HRIS decline. • Insurance cost ratio 90.75% - 89.25%. • Operating expenses to reduce mid-single digits. • Adjusted EBITDA margin 7.5% - 8.7%. • GAAP EPS $2.15 - $3.05, adjusted EPS $3.70 - $4.70. • Board authorized increase in share repurchase program to $400M.
Risks
• External headwinds like health care inflation and hiring market conditions beyond control. • Uncertainty in medical cost trends and CIE growth affecting financial performance. • Dependence on exogenous factors like interest rates and tax refund timings.
Q&A highlights
Q: Discuss guidance philosophy including difference vs predecessor.
A: Based on 2025 business momentum, OpEx discipline, revenue drivers, last repricing impact, ASO growth, and focus on controllable priorities.
Q: Bookings expectations for 2026.
A: Sales improving, new sales and retention driving volume growth, senior reps and Ascend program boding well.
Q: Insurance pricing and attrition impact.
A: Need to price for cost increases and catch-up, seen improvement in Q4 ICR, encouraged by April 1 receptiveness.
Q: CIE hiring trends.
A: Hiring suppressed, terminations stable, informing CIE assumptions.
Q: Retention outside mispriced cohort.
A: Value delivered and service quality improving, reducing 'for term' reasons.
Q: ASO services growth sources.
A: Conversion of SaaS-only clients, new sales, brokerage channel opportunities.
Q: Insurance ratio guidance assumptions.
A: Continuation of trends, informed by medical and pharmaceutical inflation, tightened range.
Q: WSE month-to-month dynamics.
A: Not giving specific month-to-month color.
Q: Pricing relative to peers.
A: In line with market, favorably positioned compared to those with catch-up work.
Q: Sales improvement drivers 2026.
A: Brokerage channel, improving rep tenure, Ascend program.
Q: WSE rollover issue.
A: Confidence in improving trend as 2026 progresses with controllable efforts.
Key numbers
Reported versus consensus
Earnings calendar feed
| Metric | Reported | Consensus | Delta | Prior year |
|---|---|---|---|---|
| EPS | $0.46 | $0.37 | +24.7% | $0.44 |
| Revenue | $1.25B | $322.0M | +287.6% | $1.33B |
Transcript
February 12, 2026Full transcript unavailable for redistribution
The structured summary above covers the available call sections. Full transcript text is not included on this page.
Continue exploring
Prior quarters
This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.